Results 101 to 110 of about 31,772 (155)

Quality of life and care experiences in a US multi-institutional neuroendocrine tumor cohort. [PDF]

J Natl Cancer Inst
O'Rorke MA, Xu T, DeCook RR, McDowell BD, Gryzlak BM, Rudzianski NJ, Serrano KC, Wehrheim AM, Grewal US, Chandrasekharan C, Dillon JS, Halfdanarson TR, Gamblin TC, Cowell LG, Else T, Soares HP, Sukrithan V, Chandaka S, Sanoff HK, He FC, Geller D, Ramirez RA, Liu M, Lancaster W, Mailman JA, Moran H, Wahmann M, Gellerman E, Chrischilles EA, NET-PRO Study Investigators .   +29 more
europepmc   +1 more source

The risk of neoplasms in appendiceal abscess: what emergency surgeons should know. [PDF]

Front Oncol
Montori G, Podda M, Giordano A, Procida G, Butera V, Murzi V, Fugazzola P, Bergamini C, Catena F, Ansaloni L, Pisanu A, Agresta F.   +11 more
europepmc   +1 more source

Microwave Ablation of Pulmonary Carcinoid Tumor: A Therapeutic Alternative for Inoperable Cases. [PDF]

J Belg Soc Radiol
Nzoyisaba T, Goyers JF.
europepmc   +1 more source

Case report of an appendiceal neuroendocrine tumor (carcinoid) combined with a parovarian cyst in an adolescent. [PDF]

Front Oncol
Tian Y, Wu Y, Hao F, Liu X, Kong M.
europepmc   +1 more source

Successful Management of Ectopic Adrenocorticotropin-Secreting Thymic Carcinoid With Mitotane: A New Look at an Old Drug. [PDF]

JCEM Case Rep
Zhou X, Xu Y, Peng X, Hu R, Lu L.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapy of the Malignant Carcinoid Syndrome

Endocrinology and Metabolism Clinics of North America, 1989
Although usually associated with carcinoid tumors of the small intestine that have metastasized to the liver, the carcinoid syndrome is seen less frequently with primary tumors arising from other organs such as the lung, pancreas, thymus, stomach, and ovary.
Larry K Kvols
exaly   +3 more sources

Cutaneous manifestations of the malignant carcinoid syndrome

British Journal of Dermatology, 2005
The incidence of carcinoid tumours is approximately 1.5 per 100 000 of the population. The malignant carcinoid syndrome, which is caused by circulating neuroendocrine mediators produced by the tumour, occurs in less than 10% of patients. Cutaneous involvement, although recognized in this rare syndrome, has rarely been reported.To examine a series of ...
G J Poston
exaly   +3 more sources

Results of Pharmacologic Treatment in the Malignant Carcinoid Syndrome

New England Journal of Medicine, 1962
THE patient with the malignant carcinoid syndrome is confronted with a group of uncomfortable and debilitating symptoms. These may include recurrent acute flushing, colicky abdominal pains, violent and profuse watery diarrhea, tachycardia, asthma-like wheezing and, less often, profound weakness, depression or agitation, dyspnea and dependent edema ...
A L, URELES, M, MURRAY, R, WOLF
exaly   +3 more sources

Malignant carcinoid syndrome: Two case reports

Journal of Surgical Oncology, 1980
AbstractThe malignant carcinoid syndrome (MCS) is a rare complication of malignant carcinoid neoplasms, fewer than 200 cases having been reported since its description by Thorson in 1954. Its signs and symptoms vary with the site of the primary neoplasm, and MCS is now recognized as one member of the large family of endocrine tumors ‐ APUDOMAS ...
J L, Spann, D, Van Wormer, M E, Sandlin
exaly   +3 more sources